Mukka Proteins board meeting scheduled for May 15, 2026 to approve FY26 audited results.
Board to consider raising ₹25 crore via private placement of non-convertible debentures.
Additional ₹50 crore NCD issuance planned in tranches via electronic bidding platform.
Trading window closed since April 1, 2026 until 48 hours after results declaration.